OBIO – orchestra biomed holdings, inc. - ordinary shares (US:NASDAQ)
Stock Stats
News
Analyst Confidence in Orchestra BioMed Holdings (OBIO) High Amid Key Clinical and Strategic Advancements [Yahoo! Finance]
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Orchestra BioMed (NASDAQ:OBIO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Orchestra BioMed (NASDAQ:OBIO) had its price target lowered by analysts at Barclays PLC from $12.00 to $11.00. They now have an "overweight" rating on the stock.
Form 4 Orchestra BioMed Holding For: Nov 25 Filed by: Taylor Andrew Lawrence
Form 4 Orchestra BioMed Holding For: Nov 25 Filed by: Sherman Darren
Form 424B3 Orchestra BioMed Holding
Form SCHEDULE 13G Orchestra BioMed Holding Filed by: Tasso Partners, LLC
Form 4 Orchestra BioMed Holding For: Nov 14 Filed by: Hochman David P
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.